[1]
Aguiar Júnior, P., Barreto, C.M.N., Roitberg, F., Lopes Júnior, G. e del Giglio, A. 2019. Potential life years not saved due to lack of access to anti-EGFR tyrosine kinase inhibitors for lung cancer treatment in the Brazilian public healthcare system: Budget impact and strategies to improve access. A pharmacoeconomic study. São Paulo Medical Journal. 137, 6 (dez. 2019), 505–511.